The Guardian -
7 Sep 2021 02:31

Five countries are assessing the test marketed under the brand name Nifty amid regulatory concerns about genetic data being sent abroad Health regulators in five countries are examining a prenatal test that collects the DNA of women and foetuses for research after it emerged the test's manufacturer has links to China's military. Some doctors and clinics that promoted and sold the test, marketed under the brand name Nifty, said they were unaware that Shenzhen-based BGI Group also conducts researc...
Share this Article